24th of August, 2022: We have included 500 patients!
16th of May, 2022: We have included 200 patients!
16th of May, 2022: TRAUMOX2 started recruiting at Aarhus University Hospital (AUH), Aarhus
6th of May, 2022: TRAUMOX2 started recruiting at Erasmus MC, University Medical Center (EMC) in Rotterdam
10th of March, 2022: TRAUMOX2 started recruiting at Odense University Hospital (OUH), Odense
7th of February, 2022: 50 patients have been included!
23rd of December, 2021: 10 patients have been included!
7th of December, 2021: TRAUMOX2 started recruiting at Rigshospitalet, Copenhagen
20th of October, 2021: The Danish Research Ethics Committee has approved TRAUMOX2 at all Danish sites (journal number: H-21018062)
16th of April, 2021: Approval was given by the Danish Medicines Agency (EudraCT number: 2021-000556-19)
12th of March, 2021: Approval applications are sent to the Danish Research Ethics Committee and the Danish Medicines Agency